Antiplatelet Effect of Different Loading Doses of Ticagrelor in Patients With Non–ST-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: The APELOT Trial-Reference-Cited by-同舟云学术

Antiplatelet Effect of Different Loading Doses of Ticagrelor in Patients With Non–ST-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: The APELOT Trial

Published:2017-12 Issue:12 Volume:33 Page:1675-1682
ISSN:0828-282X
Container-title:Canadian Journal of Cardiology
language:en
Short-container-title:Canadian Journal of Cardiology

Author:

Liu Hui-Liang,Wei Yu-Jie,Ding Peng,Zhang Jiao,Li Tian-Chang,Wang Bing,Wang Ming-Sheng,Li Yun-Tian,Zhang Jian-Jun,Ren Yi-Hong,Tang Qiang,Luo Jian-Ping,Yang Sheng-Li,Ma Hong-Yu,Liu Ying,Han Wei,Li Yi,Jin Zhi-Geng,Jin Li-Min

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Population trends in the incidence and outcomes of acute myocardial infarction;Yeh;N Engl J Med,2010

2. Mortality rates in patients with ST-elevation vs non-ST-elevation acute myocardial infarction: observations from an unselected cohort;Terkelsen;Eur Heart J,2005

3. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology;Rapezzi;Eur Heart J,2008

4. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate;Bonello;J Am Coll Cardiol,2010

5. Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis;Aradi;Am Heart J,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of pretreatment with a P2Y12 inhibitor in patients with non-ST-elevation acute coronary syndrome: a systematic review and network meta-analysis;Frontiers in Cardiovascular Medicine;2023-07-19

2. Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth?;Journal of Clinical Medicine;2022-12-04

3. Oral Antiplatelet Agents in Percutaneous Coronary Intervention;Interventional Cardiology;2022-05-06

4. Tackling the gap in platelet inhibition with oral antiplatelet agents in high-risk patients undergoing percutaneous coronary intervention;Expert Review of Cardiovascular Therapy;2021-05-11

5. 2020 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y12 Receptor Antagonists in the Asia-Pacific Region;European Cardiology Review;2021-03-02